Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    HomeNewsGlaxosmithkline

    Glaxosmithkline

    Jump to
    • GlaxoSmithKline Standalone September 2025 Net Sales at Rs 973.63 crore, down 2.64% Y-o-Y

      GlaxoSmithKline Standalone September 2025 Net Sales at Rs 973.63 crore, down 2.64% Y-o-Y

    • GlaxoSmithKline Consolidated September 2025 Net Sales at Rs 979.94 crore, down 3.05% Y-o-Y

      GlaxoSmithKline Consolidated September 2025 Net Sales at Rs 979.94 crore, down 3.05% Y-o-Y

    • GlaxoSmithKline Consolidated June 2025 Net Sales at Rs 805.17 crore, down 1.16% Y-o-Y

      GlaxoSmithKline Consolidated June 2025 Net Sales at Rs 805.17 crore, down 1.16% Y-o-Y

    • GlaxoSmithKline Standalone June 2025 Net Sales at Rs 804.83 crore, down 0.76% Y-o-Y

      GlaxoSmithKline Standalone June 2025 Net Sales at Rs 804.83 crore, down 0.76% Y-o-Y

    • GlaxoSmithKline Standalone March 2025 Net Sales at Rs 966.08 crore, up 6.06% Y-o-Y

      GlaxoSmithKline Standalone March 2025 Net Sales at Rs 966.08 crore, up 6.06% Y-o-Y

    • GlaxoSmithKline Consolidated March 2025 Net Sales at Rs 974.37 crore, up 4.79% Y-o-Y

      GlaxoSmithKline Consolidated March 2025 Net Sales at Rs 974.37 crore, up 4.79% Y-o-Y

    • GlaxoSmithKline Consolidated December 2024 Net Sales at Rs 949.42 crore, up 17.9% Y-o-Y

      GlaxoSmithKline Consolidated December 2024 Net Sales at Rs 949.42 crore, up 17.9% Y-o-Y

    • GlaxoSmithKline Consolidated September 2024 Net Sales at Rs 1,010.77 crore, up 5.62% Y-o-Y

      GlaxoSmithKline Consolidated September 2024 Net Sales at Rs 1,010.77 crore, up 5.62% Y-o-Y

    • GlaxoSmithKline Standalone September 2024 Net Sales at Rs 1,000.05 crore, up 4.9% Y-o-Y

      GlaxoSmithKline Standalone September 2024 Net Sales at Rs 1,000.05 crore, up 4.9% Y-o-Y

    • GlaxoSmithKline Consolidated June 2024 Net Sales at Rs 814.65 crore, up 6.96% Y-o-Y

      GlaxoSmithKline Consolidated June 2024 Net Sales at Rs 814.65 crore, up 6.96% Y-o-Y

    • GlaxoSmithKline Standalone June 2024 Net Sales at Rs 811.00 crore, up 9.89% Y-o-Y

      GlaxoSmithKline Standalone June 2024 Net Sales at Rs 811.00 crore, up 9.89% Y-o-Y

    • GlaxoSmithKline Consolidated March 2024 Net Sales at Rs 929.80 crore, up 18.08% Y-o-Y

      GlaxoSmithKline Consolidated March 2024 Net Sales at Rs 929.80 crore, up 18.08% Y-o-Y

    • GlaxoSmithKline Standalone March 2024 Net Sales at Rs 910.87 crore, up 16.46% Y-o-Y

      GlaxoSmithKline Standalone March 2024 Net Sales at Rs 910.87 crore, up 16.46% Y-o-Y

    • GlaxoSmithKline Consolidated December 2023 Net Sales at Rs 805.26 crore, up 0.37% Y-o-Y

      GlaxoSmithKline Consolidated December 2023 Net Sales at Rs 805.26 crore, up 0.37% Y-o-Y

    • GlaxoSmithKline Standalone December 2023 Net Sales at Rs 804.98 crore, up 0.73% Y-o-Y

      GlaxoSmithKline Standalone December 2023 Net Sales at Rs 804.98 crore, up 0.73% Y-o-Y

    • GlaxoSmithKline Standalone September 2023 Net Sales at Rs 953.38 crore, up 5.27% Y-o-Y

      GlaxoSmithKline Standalone September 2023 Net Sales at Rs 953.38 crore, up 5.27% Y-o-Y

    • GlaxoSmithKline sues Pfizer over patents for RSV vaccine

      GlaxoSmithKline sues Pfizer over patents for RSV vaccine

      The suit seeks compensation for lost profits and royalties and a permanent ban on Pfizer selling the product in the United States.

    • GlaxoSmithKline Consolidated June 2023 Net Sales at Rs 761.66 crore, up 2.22% Y-o-Y

      GlaxoSmithKline Consolidated June 2023 Net Sales at Rs 761.66 crore, up 2.22% Y-o-Y

    • GlaxoSmithKline Standalone June 2023 Net Sales at Rs 738.02 crore, up 1.17% Y-o-Y

      GlaxoSmithKline Standalone June 2023 Net Sales at Rs 738.02 crore, up 1.17% Y-o-Y

    • GlaxoSmithKline Standalone March 2023 Net Sales at Rs 782.16 crore, down 1.23% Y-o-Y

      GlaxoSmithKline Standalone March 2023 Net Sales at Rs 782.16 crore, down 1.23% Y-o-Y

    • GlaxoSmithKline Consolidated March 2023 Net Sales at Rs 787.45 crore, down 2.74% Y-o-Y

      GlaxoSmithKline Consolidated March 2023 Net Sales at Rs 787.45 crore, down 2.74% Y-o-Y

    • GlaxoSmithKline Standalone December 2022 Net Sales at Rs 799.11 crore, down 1.1% Y-o-Y

      GlaxoSmithKline Standalone December 2022 Net Sales at Rs 799.11 crore, down 1.1% Y-o-Y

    • GlaxoSmithKline Consolidated December 2022 Net Sales at Rs 802.30 crore, down 1.67% Y-o-Y

      GlaxoSmithKline Consolidated December 2022 Net Sales at Rs 802.30 crore, down 1.67% Y-o-Y

    • GlaxoSmithKline Standalone September 2022 Net Sales at Rs 905.61 crore, down 8.67% Y-o-Y

      GlaxoSmithKline Standalone September 2022 Net Sales at Rs 905.61 crore, down 8.67% Y-o-Y

    • GlaxoSmithKline Consolidated September 2022 Net Sales at Rs 916.87 crore, down 9.21% Y-o-Y

      GlaxoSmithKline Consolidated September 2022 Net Sales at Rs 916.87 crore, down 9.21% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347